Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Spdr S&P Biotech Etf XBI

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests... see more

Opinion & Analysis (ARCA:XBI)

Let volatility power your micro-cap biotechs

The Life Sciences Report April 28, 2016

Breaking Down Biotech ETFs With Leverage

Benzinga.com  October 2, 2015

ETF Outlook: More Biotech Blunders Or A Biotech Bounce?

Benzinga.com  September 27, 2015

Traders Bet Against Hillary With Leveraged Biotech ETF

Benzinga.com  September 23, 2015

Investors In This Biotech ETF Must Have Loved Hillary Clinton's Tweet

Benzinga.com  September 22, 2015

A Bad Sign For Biotech Bulls

Benzinga.com  August 20, 2015

This Week's ETF's To Watch: A Lot Of Familiar Faces

Benzinga.com  August 9, 2015

A Bad Week For Biotech Was Great For This ETF

Benzinga.com  August 7, 2015

Even With Recent Declines, Investors Still Love Biotech ETFs

Benzinga.com  July 30, 2015

A Big Day For Biotech And It's Not Going So Well

Benzinga.com  July 27, 2015

The Best (And Worst) ETFs Of Last Week Amid Social Media's Collapse

Benzinga.com  May 3, 2015

The Best Biotech ETF Isn't Always The Biggest

Benzinga.com  February 25, 2015

Energy, TIPs And Biotechnology ETFs To Watch This Week

Benzinga.com  February 2, 2015

Biotech Stocks Sell Off, ETFs Fall Over 5%

Benzinga.com  December 23, 2014

Health Care ETFs Take Over Market Leadership Role

Benzinga.com  December 5, 2014

Capitalizing on the "V-Bottom" with UTHR

Benzinga.com  October 21, 2014

Best And Worst ETFs Of The Week Amid Market Rebound

Benzinga.com  October 17, 2014

Earnings Beats Drive ETFs; LinkedIn Boosts Social Media ETF

Benzinga.com  July 24, 2014

Cheer Up! A Portfolio Pep Talk For Investors

Benzinga.com  May 16, 2014

6 Charts That Help Explain What's Been Happening In The Momentum Names Lately

Benzinga.com  May 5, 2014